Skip to content
Home / News |

Here’s Why BXP Share Price Surged 48.2% Today

Beximco Pharma logo
Simon Mugo

Shares of Beximco Pharmaceuticals (LON: BXP) today surged 48.2% after the company announced an exclusive deal with the Serum Institute of India to be the sole supplier of the COVID-19 vaccine in Bangladesh.

The deal will see Beximco contribute funds to facilitate the vaccine’s development, which will be adjusted according to the vaccine’s final pricing.

The Serum Institute has partnered with AstraZeneca, the Gates Foundation and Gavi to produce over a billion vaccines for global distribution.

X testing X
WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.
Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.
5.0
Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Beximco clarified that the vaccines supplied to Bangladesh will be on a priority basis and that its investment will depend on regulatory approvals, SII’s production capacity and its earlier commitments to other countries.

BXP share price

Tradingview chart of BXP share price 28082020

Source: Tradingview

BXP shares today surged 48.2% to trade at 81.5p having ended yesterday’s session trading at 55.0p.

Simon Mugo
Simon Mugo
Contributor

Simon ist Autor und Analyst für den Bereich Finanzwesen und blickt auf über sechs Jahre professionelle Erfahrung als Trader zurück. Er absolvierte einen Bachelor in Mathematik und Informatik und hat eine Leidenschaft für die Finanzmärkte. Simon handelt FX, Rohstoffe und Aktien. Er konzentriert sich auf Price Action Trading.